Skip to main content
Log in

Seroepidemiology of hepatitis A in Delhi

  • Original Article
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

A prospective study was done to determine the age specific prevalence of antihepatitis A antibodies (anti HAV Abs) among children in Delhi. Four hundred and twenty children aged 0–12 years attending outpatient department for vaccination or any minor illness were studied. Sera was tested by ELISA for anti HAV Abs using a commercial kit (Hepvase A 96 TMB). Thirty samples of cord blood were similarly analyzed. All samples of cord blood were positive for anti HAV Abs. Prevalence of anti HAV Abs was 80% by 5 years of age. The most vulnerable age group was 0.5–1.5 years (anti HAV Ab positivity). Cord blood had 100% positivity. Univariate and multivariate analyses taking anti HAV antibody positivity as dependant variable demonstrated that age and father’s education (socioeconomic status) significantly affect prevalence of anti HAV Abs. Sex, water supply, history of jaundice in self or family did not have any significant effect on anti HAV antibody positivity. Prevalence of anti HAV antibodies is 80% by 5 years of age. Further studies in different strata of society and different regions in the country are required to assess the need and age for vaccination.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Melnick JL. History and epidemiology of Hepatitis A virus.J Pediatr lnf Dis 1995; 1171 (suppl 1): 52–58.

    Google Scholar 

  2. Thapa BR, Singh K, Singh Vet al. Patterns of Hepatitis A and B virus markers in cases of acute sporadic hepatitis and in healthy school children from North West India.J Trop Pediatr 1995; 41: 328–329.

    PubMed  CAS  Google Scholar 

  3. Tandon BN, Gandhi MB, Joshi YK. Etiological spectrum of viral hepatitis and prevalence of markers of hepatitis A and B virus infection in North India.Bull WHO 1984; 62 (1): 67–73.

    PubMed  CAS  Google Scholar 

  4. Hollinger FB, Theodore E, Gershon A, Jong EC. Koff RS. Discussion: who should receive Hepatitis A (Vaccine). A strategy for controlling hepatitis A.J Infect Dis 1995; 171 (suppl): 573–577.

    Google Scholar 

  5. Arankalle VA, Tsarev SA, Chadha MSet al.Age specific prevalence of antibodies to hepatitis A and E virus in Pune, India 1982 and 1992.J Infect Dis 1995; 171 (2): 447–450.

    PubMed  CAS  Google Scholar 

  6. Nutrition subcommittee of the Indian Academy of Pediatrics. Report.Indian Pediatr 1972; 9 :360–368.

    Google Scholar 

  7. Gandhi BM, Joshi YK, Tandon BN. Prevalence of virus A exposure and viral hepatitis A in India.Lancet 1981, (ii): 374–375.

    Article  Google Scholar 

  8. Yap I, Guan R. Hepatitis A seroepidemiology in Singapore, a changing pattern.Trans Royal Society Trop Med 1993; 87: 22–23.

    Article  CAS  Google Scholar 

  9. Urn DS, Cho KH, Kim HC. Seroepidemiological study of Anti-HAV antibody in Cheonbuk Province in 1989.Korean J lnt Med 1992; 43:43–46.

    Google Scholar 

  10. Heng BH, Goh KT, Doriasingham S, Quek GH. Prevalence of hepatitis A infection among sewage workers in Singapore.Epidemiol Infect 1994; 113: 121–128.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dutta, A.K., Aggarwal, A., Kapoor, A.K. et al. Seroepidemiology of hepatitis A in Delhi. Indian J Pediatr 67, 77–79 (2000). https://doi.org/10.1007/BF02726169

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02726169

Key words

Navigation